Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Enliven Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Enliven Therapeutics Inc. June 18, 202495.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +87,373 | $2.48 | $216,685 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +27,567 | $25.28 | $696,894 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +23,364 | $14.85 | $346,955 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Option exercise | +20,491 | $22.47 | $460,433 |
| Aug 4, 2026 | Enliven Therapeutics Inc. | Open-market sale | −158,795 | $60.21 | $9,561,047 |
Questions about Mika K. Derynck
What boards is Mika K. Derynck on?
Mika K. Derynck sits on the board of Enliven Therapeutics Inc.
How long has Mika K. Derynck served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.